Clinical Trial Update: Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of doxorubicin with hyperthermic intraperitoneal chemotherapy (HIPEC) and intraoperative brachytherapy for unresectable or refractory p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma
• Undifferentiated Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Malignant Neoplasms of Mesothelial and Soft Tissue, Rhabdomyosarcoma, Pelvic | Phase 1 | Status: WITHDRAWN